Federal grants to Imcare Biotech, Inc.
Imcare Biotech, Inc. in Doylestown, Pennsylvania received $4.5 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cancer Detection and Diagnosis Research, with $4.5 million. In fiscal 2025 it was awarded $364,763.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.5 million
- Awards3
- Awarded in FY 2025$364,763
- Largest award$4.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.6 million |
| FY 2022 | 1 | $1.3 million |
| FY 2023 | 1 | $1.3 million |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $364,763 |
Programs that fund Imcare Biotech, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Detection and Diagnosis Research | 3 | $4.5 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $4.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A novel diagnostic biomarker for hepatocellular carcinoma(HCC) | Cancer Detection and Diagnosis Research | November 9, 2020 | $4.0 million |
| A novel multi-analyte algorithmic assay diagnostic for hepatocellular carcinoma (HCC). - project summary imcare biotech is seeking to develop and validate seravue ai, a novel multi-analyte algorithmic assay for early detection of hepatocellular carcinoma (HCC), the most common type of primary liver | Cancer Detection and Diagnosis Research | June 20, 2025 | $364,763 |
| Comprehensive intellectual property, reimbursement, and licensing strategy for imcare biotech's diagnostic product seravue - abstract imcare biotech has developed a highly accurate and specific elisa based diagnostic assay for hepatocellular carcinoma. Trademark pending as seravuetm, the test quanti | Cancer Detection and Diagnosis Research | March 25, 2021 | $166,729 |
Questions people ask
How much federal grant money does Imcare Biotech, Inc. get?
$4.5 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Imcare Biotech, Inc. the most?
The Department of Health and Human Services, with $4.5 million in 3 awards.
What is Imcare Biotech, Inc.'s largest federal grant?
$4.0 million under Cancer Detection and Diagnosis Research, with its first action in the period on November 9, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Doylestown
- Bucks, the County of
- Bucks County Intermediate Unit 22
- Fox Chase Chemical Diversity Center Inc.
- Bucks County Housing Authority
- Delaware Valley University
- River Crossing Young Men's Christian Association
- Baruch S. Blumberg Institute
- Evrys Bio, Inc.
Largest federal grant recipients in Pennsylvania · Federal grants in Pennsylvania